Literature DB >> 20848144

Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome.

Hong-Yan Qin1, Justin C Y Wu, Xu-Dong Tong, Joseph J Y Sung, Hong-Xi Xu, Zhao-Xiang Bian.   

Abstract

AIMS: Post-infectious irritable bowel syndrome (PI-IBS) is a subset of IBS which occurs after an episode of acute gastrointestinal infections. The mechanisms of PI-IBS are not fully understood. Currently, numerous animal models have been used in the study of PI-IBS. This article reviews the strengths and weaknesses of these models.
METHODS: All relevant articles were identified by searching in Ovid SP from 1962, the year the term PI-IBS was coined, up to December 31, 2009. The types of model were categorized as either post-infectious or post-inflammatory, and the characteristics of each kind of model were listed.
RESULTS: Based on our literature search, 268 articles were identified. Of those articles, 50 were included in this review. The existing PI-IBS models include infection with bacteria (e.g., Campylobacter jejuni, Salmonella enterica, and Campylobacter rodentium), and infection with parasites (e.g., Trichinella spiralis, Nippostrongylus brasiliensis, and Cryptosporidium parvum). The post-inflammatory IBS models are commonly induced with chemical agents, such as acetic acid, deoxycholic acid, dextran sulfate sodium, mustard oil, zymosan, and trinitrobenzene sulfonic acid (TNBS). TNBS is the most commonly used agent for post-inflammatory IBS models, but the experimental protocol varies. These models have one or more aspects similar to IBS patients.
CONCLUSIONS: Different methods have been used for the development of post-infectious or post-inflammatory IBS models. Each model has its weaknesses and strengths. More studies are needed to establish post-infection IBS models using more common pathogens. A standard protocol in developing TNBS-induced post-inflammatory IBS model is needed.

Entities:  

Mesh:

Year:  2010        PMID: 20848144     DOI: 10.1007/s00535-010-0321-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  104 in total

1.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

2.  Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation.

Authors:  H Allgayer; K Deschryver; W F Stenson
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

3.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

4.  Irritable bowel syndrome in persons who acquired trichinellosis.

Authors:  Mujde Soyturk; Hale Akpinar; Oguz Gurler; Edoardo Pozio; Ismail Sari; Servet Akar; Mesut Akarsu; Merih Birlik; Fatos Onen; Nurullah Akkoc
Journal:  Am J Gastroenterol       Date:  2007-02-21       Impact factor: 10.864

5.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.

Authors:  L-H Wang; X-C Fang; G-Z Pan
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

6.  Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.

Authors:  B J R Whittle; C Varga; A Berko; K Horvath; A Posa; J P Riley; K A Lundeen; A M Fourie; P J Dunford
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

7.  Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension.

Authors:  K Saito-Nakaya; R Hasegawa; Y Nagura; H Ito; S Fukudo
Journal:  Neurogastroenterol Motil       Date:  2008-08-28       Impact factor: 3.598

8.  Reversal of visceral and somatic hypersensitivity in a subset of hypersensitive rats by intracolonic lidocaine.

Authors:  Qiqi Zhou; Donald D Price; G Nicholas Verne
Journal:  Pain       Date:  2008-05-16       Impact factor: 6.961

9.  Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.

Authors:  V Dizdar; O H Gilja; T Hausken
Journal:  Neurogastroenterol Motil       Date:  2007-08-17       Impact factor: 3.598

10.  Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation.

Authors:  Paul L Beck; Yan Li; J Wong; Chang-Wen Chen; Catherine M Keenan; Keith A Sharkey; Donna-Marie McCafferty
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

View more
  42 in total

1.  Immune/Inflammatory Response and Hypocontractility of Rabbit Colonic Smooth Muscle After TNBS-Induced Colitis.

Authors:  Yonggang Zhang; Fang Li; Hong Wang; Chaoran Yin; JieAn Huang; Sunila Mahavadi; Karnam S Murthy; Wenhui Hu
Journal:  Dig Dis Sci       Date:  2016-02-15       Impact factor: 3.199

2.  Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period.

Authors:  Amandine Lashermes; Ludivine Boudieu; Julie Barbier; Benoit Sion; Agathe Gelot; Nicolas Barnich; Denis Ardid; Frédéric Antonio Carvalho
Journal:  Gut Microbes       Date:  2017-10-04

3.  Arsenic trioxide ameliorates murine colon inflammation through inflammatory cell enzymatic modulation.

Authors:  Hichem Moulahoum; Belkacem Mohamed Amine Boumaza; Meriem Ferrat; Abdelkader Bounaama; Bahia Djerdjouri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-10       Impact factor: 3.000

Review 4.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

5.  Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling.

Authors:  Xiaolun Sun; Deborah Threadgill; Christian Jobin
Journal:  Gastroenterology       Date:  2011-10-01       Impact factor: 22.682

6.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

7.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

Review 8.  Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.

Authors:  Jennifer K Beatty; Amol Bhargava; Andre G Buret
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

9.  Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.

Authors:  Xiao-Yan Zhou; Ming Li; Xia Li; Xin Long; Xiu-Li Zuo; Xiao-Hua Hou; Ying-Zi Cong; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

10.  Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome.

Authors:  Giovanni Barbara; Madhusudan Grover; Premysl Bercik; Maura Corsetti; Uday C Ghoshal; Lena Ohman; Mirjana Rajilić-Stojanović
Journal:  Gastroenterology       Date:  2018-11-28       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.